Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
8.62
+0.32 (3.86%)
Apr 24, 2026, 4:29 PM CET
Market Cap2.05B +4,469.8%
Revenue (ttm)n/a
Net Income-45.91M
EPS-0.44
Shares Out238.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,510,519
Average Volume26,473,491
Open8.47
Previous Close8.30
Day's Range8.10 - 9.00
52-Week Range0.55 - 14.46
Beta-1.21
RSI52.92
Earnings DateApr 15, 2026

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company has a research collaboration with United Immunity Co., Ltd. for the dev... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements